Litcius/Paper detail

Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas

Enrico Franceschi, Alicia Tosoni, Stefania Bartolini, Santino Minichillo, Antonella Mura, Sofia Asioli, Daniela Bartolini, Marina Gardiman, Marco Gessi, Claudio Ghimenton, Felice Giangaspero, Giovanni Lanza, Gianluca Marucci, Mariangela Novello, Enrico Maria Silini, Elena Zunarelli, Alexandro Paccapelo, Alba A. Brandes

2020European Journal of Cancer50 citationsDOI

Topics & Concepts

MedicineGrading (engineering)Internal medicineHazard ratioIsocitrate dehydrogenaseGastroenterologyIDH1Confidence intervalBiopsyGliomaRadiation therapyOncologyPathologyMutationBiologyCancer researchGeneEnzymeBiochemistryEcologyGlioma Diagnosis and TreatmentMeningioma and schwannoma managementNeuroblastoma Research and Treatments
Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas | Litcius